ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
ALTERITY THERAPEUTICS LTD
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026
$2.43−0.19 (-7.25%)
Close on Oct 19, 2026
Share price
−$2.46 (−50.31%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Free cash flow
- -A$22.52M
Valuation needs the share price. It fills in once daily prices are connected and converted from AUD.
Twelve years at a glance
Fiscal years 2015 to 2026, AUD
Revenue
–
Net income
–
EPS, diluted
–
Free cash flow
-A$22.52M
Reported period